NPC
SGYP

National Planning Corporation’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

National Planning Corporation’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$29K – 688
2017
Q3 		$29K Buy
+10,000
New +$34.1K ﹤0.01% 677

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Planning Corporation's SGYP Position: Q4 2017 in Review

National Planning Corporation sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 10,000 shares — an estimated $29K sold.

National Planning Corporation first reported a position in SGYP in Q3 2017 and held it in 1 quarter. The position peaked at $29K in Q3 2017. 149 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

  • National Planning Corporation reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 10,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $29K.
  • National Planning Corporation first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2017 and held it in 1 quarter.
  • National Planning Corporation's Synergy Pharmaceuticals, Inc Common Stock position peaked at $29K in Q3 2017.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.